[ad_1]
Bell, B. G., Schellevis, F., Stobberingh, E., Goossens, H. & Pringle, M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect. Dis. 14, 13 (2014).
Goossens, H., Ferech, M., Vander Stichele, R. & Elseviers, M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365, 579–587 (2005).
Yelin, I. et al. Personal clinical history predicts antibiotic resistance of urinary tract infections. Nat. Med. 25, 1143–1152 (2019).
Didelot, X., Walker, A. S., Peto, T. E., Crook, D. W. & Wilson, D. J. Within-host evolution of bacterial pathogens. Nat. Rev. Microbiol. 14, 150–162 (2016).
Stracy, M. et al. Minimizing treatment-induced emergence of antibiotic resistance in bacterial infections. Science 375, 889–894 (2022).
Friedman, N. D., Temkin, E. & Carmeli, Y. The negative impact of antibiotic resistance. Clin. Microbiol. Infect. 22, 416–422 (2016).
Aloush, V., Navon-Venezia, S., Seigman-Igra, Y., Cabili, S. & Carmeli, Y. Multidrug-resistant Pseudomonas aeruginosa: Risk factors and clinical impact. Antimicrob. Agents Chemother. 50, 43–48 (2006).
Wheatley, R. et al. Rapid evolution and host immunity drive the rise and fall of carbapenem resistance during an acute Pseudomonas aeruginosa infection. Nat. Commun. 12, 1–12 (2021).
Eldholm, V. et al. Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patient. Genome Biol. 15, 490 (2014).
Lieberman, T. D. et al. Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. Nat. Genet. 43, 1275–U1148 (2011).
Juan, C. et al. Contribution of clonal dissemination and selection of mutants during therapy to Pseudomonas aeruginosa antimicrobial resistance in an intensive care unit setting. Clin. Microbiol. Infect. 11, 887–892 (2005).
Hughes, D. & Andersson, D. I. in Annual Review of Microbiology Vol. 71 (ed. Gottesman, S.) 579–596 (Annual Reviews, 2017).
Moxon, E. R. & Murphy, P. A. Haemophilus influenzae bacteremia and meningitis resulting from survival of a single organism. Proc. Natl Acad. Sci. USA 75, 1534–1536 (1978).
Gerlini, A. et al. The role of host and microbial factors in the pathogenesis of pneumococcal bacteraemia arising from a single bacterial cell bottleneck. PLoS Pathog. 10, e1004026 (2014).
Young, B. C. et al. Evolutionary dynamics of Staphylococcus aureus during progression from carriage to disease. Proc. Natl Acad. Sci. USA 109, 4550–4555 (2012).
Kono, M. et al. Single cell bottlenecks in the pathogenesis of Streptococcus pneumoniae. PLoS Pathog. 12, e1005887 (2016).
Balmer, O. & Tanner, M. Prevalence and implications of multiple-strain infections. Lancet Infect. Dis. 11, 868–878 (2011).
Warren, R. M. et al. Patients with active tuberculosis often have different strains in the same sputum specimen. Am. J. Respir. Crit. Care Med. 169, 610–614 (2004).
Nathavitharana, R. R. et al. Polyclonal pulmonary tuberculosis infections and risk for multidrug resistance, Lima, Peru. Emerg. Infect. Dis. 23, 1887 (2017).
Wewalka, G., Schmid, D., Harrison, T., Uldum, S. & Lück, C. Dual infections with different Legionella strains. Clin. Microbiol. Infect. 20, O13–O19 (2014).
Hilliam, Y. et al. Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung. Eur. Respir. J. 49, 1602108 (2017).
Williams, D. et al. Divergent, coexisting Pseudomonas aeruginosa lineages in chronic cystic fibrosis lung infections. Am. J. Respir. Crit. Care Med. 191, 775–785 (2015).
Barrett, R. D. & Schluter, D. Adaptation from standing genetic variation. Trends Ecol. Evol. 23, 38–44 (2008).
Bitter, M., Kapsenberg, L., Gattuso, J.-P. & Pfister, C. Standing genetic variation fuels rapid adaptation to ocean acidification. Nat. Commun. 10, 1–10 (2019).
Jones, F. C. et al. The genomic basis of adaptive evolution in threespine sticklebacks. Nature 484, 55–61 (2012).
Pena, C. et al. Carbapenem-resistant Pseudomonas aeruginosa: factors influencing multidrug-resistant acquisition in non-critically ill patients. Eur. J. Clin. Microbiol. Infect. Dis. 28, 519–522 (2009).
Juan, C., Peña, C. & Oliver, A. Host and pathogen biomarkers for severe Pseudomonas aeruginosa infections. J. Infect. Dis. 215, S44–S51 (2017).
Kang, C.-I. et al. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin. Infect. Dis. 37, 745–751 (2003).
Pachori, P., Gothalwal, R. & Gandhi, P. Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review. Genes Dis. 6, 109–119 (2019).
Zhang, Y. et al. Mortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studies. Emerg. Microbes Infect. 5, e27 (2016).
Fish, D. N., Piscitelli, S. C. & Danziger, L. H. Development of resistance during antimicrobial therapy—a review of antibiotic classes and patient characteristics in 173 studies. Pharmacotherapy 15, 279–291 (1995).
Williams, D. et al. Transmission and lineage displacement drive rapid population genomic flux in cystic fibrosis airway infections of a Pseudomonas aeruginosa epidemic strain. Microb. Genom. 4, e000167 (2018).
Paling, F. P. et al. Rationale and design of ASPIRE-ICU: a prospective cohort study on the incidence and predictors of Staphylococcus aureus and Pseudomonas aeruginosa pneumonia in the ICU. BMC Infect. Dis. 17, 643 (2017).
Wheatley, R. M. et al. Gut to lung translocation and antibiotic mediated selection shape the dynamics of Pseudomonas aeruginosa in an ICU patient. Nat. Commun. 13, 6523 (2022).
Freschi, L. et al. Clinical utilization of genomics data produced by the international Pseudomonas aeruginosa consortium. Front. Microbiol. 6, 8 (2015).
Kalil, A. C. et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin. Infect. Dis. 63, e61–e111 (2016).
Drusano, G. L. Antimicrobial pharmacodynamics: critical interactions of ‘bug and drug’. Nat. Rev. Microbiol. 2, 289–300 (2004).
del Barrio-Tofino, E., Lopez-Causape, C. & Oliver, A. Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired beta-lactamases: 2020 update. Int. J. Antimicrob. Agents 56, 9 (2020).
Torrens, G. et al. Susceptibility profiles and resistance genomics of Pseudomonas aeruginosa isolates from European ICUs participating in the ASPIRE-ICU trial. J. Antimicrob. Chemother. 77, 1862–1872 (2022).
Breidenstein, E. B. M., de la Fuente-Nunez, C. & Hancock, R. E. W. Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol. 19, 419–426 (2011).
Lopez-Causape, C., Cabot, G., del Barrio-Tofino, E. & Oliver, A. The versatile mutational resistome of Pseudomonas aeruginosa. Front. Microbiol. 9, 685 (2018).
López-Causapé, C. et al. Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone. Sci. Rep. 7, 5555 (2017).
Cabot, G. et al. Deciphering the resistome of the widespread Pseudomonas aeruginosa sequence type 175 international high-risk clone through whole-genome sequencing. Antimicrob. Agents Chemother. 60, 7415–7423 (2016).
Kos, V. N. et al. The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility. Antimicrob. Agents Chemother. 59, 427–436 (2015).
Cortes-Lara, S. et al. Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis. Clin. Microbiol. Infect. 27, 1631–1637 (2021).
Partridge, S. R., Kwong, S. M., Firth, N. & Jensen, S. O. Mobile genetic elements associated with antimicrobial resistance. Clin. Microbiol. Rev. 31, e00088–17 (2018).
Gabrielaite, M., Johansen, H. K., Molin, S., Nielsen, F. C. & Marvig, R. L. Gene Loss and acquisition in lineages of Pseudomonas aeruginosa evolving in cystic fibrosis patient airways. Mbio 11, e02359–20 (2020).
Chung, H. et al. Rapid expansion and extinction of antibiotic resistance mutations during treatment of acute bacterial respiratory infections. Nat. Commun. 13, 1231 (2022).
Vogwill, T. & MacLean, R. C. The genetic basis of the fitness costs of antimicrobial resistance: a meta-analysis approach. Evolut. Appl. 8, 284–295 (2015).
Melnyk, A. H., Wong, A. & Kassen, R. The fitness costs of antibiotic resistance mutations. Evolut. Appl. 8, 273–283 (2015).
Qi, Q., Preston, G. M. & MacLean, R. C. Linking system-wide impacts of RNA polymerase mutations to the fitness cost of rifampin resistance in Pseudomonas aeruginosa. Mbio 5, 12 (2014).
San Millan, A. S. et al. Positive selection and compensatory adaptation interact to stabilize non-transmissible plasmids. Nat. Commun. 5, 5208 (2014).
Maisnier-Patin, S. & Andersson, D. I. Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution. Res. Microbiol. 155, 360–369 (2004).
Levin, B. R., Perrot, V. & Walker, N. Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics 154, 985–997 (2000).
Horcajada, J. P. et al. Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections. Clin. Microbiol. Rev. 32, e00031–19 (2019).
Andersson, D. I. & Hughes, D. Antibiotic resistance and its cost: is it possible to reverse resistance. Nat. Rev. Microbiol. 8, 260–271 (2010).
Palmer, A. C. & Kishony, R. Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance. Nat. Rev. Genet. 14, 243–248 (2013).
Andersson, D. I. et al. Antibiotic resistance: turning evolutionary principles into clinical reality. FEMS Microbiol. Rev. 44, 171–188 (2020).
MacLean, R. C., Hall, A. R., Perron, G. G. & Buckling, A. The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts. Nat. Rev. Genet. 11, 405–414 (2010).
Fish, D. N., Piscitelli, S. C. & Danziger, L. H. Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies. Pharmacotherapy: J. Hum. Pharmacol. Drug Ther. 15, 279–291 (1995).
Saber, M. M. et al. Single nucleotide variants in Pseudomonas aeruginosa populations from sputum correlate with baseline lung function and predict disease progression in individuals with cystic fibrosis. Micro. Genom. 9, mgen000981 (2023).
Levene, H. Genetic equilibrium when more than one ecological niche is available. Am. Nat. 87, 331–333 (1953).
Jorth, P. et al. Regional isolation drives bacterial diversification within cystic fibrosis lungs. Cell Host Microbe 18, 307–319 (2015).
McCallum, S. J. et al. Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa. Lancet 358, 558–560 (2001).
Fothergill, J. L., Walshaw, M. J. & Winstanley, C. Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections. Eur. Respir. J. 40, 227–238 (2012).
Young, B. C. et al. Severe infections emerge from commensal bacteria by adaptive evolution. Elife 6, 25 (2017).
Folkesson, A. et al. Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective. Nat. Rev. Microbiol. 10, 841–851 (2012).
Greaves, M. & Maley, C. C. Clonal evolution in cancer. Nature 481, 306–313 (2012).
Maley, C. C. et al. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat. Genet. 38, 468–473 (2006).
The European Committee on Antimicrobial Susceptibility Testing. EUCAST Reading Guide for Broth Microdilution. http://www.eucast.org (2021).
The European Committee on Antimicrobial Susceptibility Testing. Breakpoint Tables for interpretation of MICs and Zone Diameters, Version 11.0. http://www.eucast.org (2021).
Wick, R. R., Judd, L. M., Gorrie, C. L. & Holt, K. E. Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput. Biol. 13, e1005595 (2017).
Li, H. et al. The sequence alignment/map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).
Walker, B. J. et al. Pilon: an integrated tool for comprehensive microbial variant detection and genome assembly improvement. PLoS ONE 9, e112963 (2014).
Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
d’Agostino, R. B. An omnibus test of normality for moderate and large size samples. Biometrika 58, 341–348 (1971).
D’AGOSTINO, R. & Pearson, E. S. Tests for departure from normality. Empirical results for the distributions of b 2 and √b. Biometrika 60, 613–622 (1973).
Marvig, R. L., Sommer, L. M., Molin, S. & Johansen, H. K. Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis. Nat. Genet. 47, 57–64 (2015).
Cingolani, P. et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w(1118); iso-2; iso-3. Fly 6, 80–92 (2012).
Letunic, I. & Bork, P. Interactive Tree Of Life (iTOL): an online tool for phylogenetic tree display and annotation. Bioinformatics 23, 127–128 (2007).
Venables, W. & Ripley, B. D. Statistics and Computing: Modern Applied Statistics with S. 978–970 (Springer-Verlag, 2002).
Tamura, K., Stecher, G. & Kumar, S. MEGA11: molecular evolutionary genetics analysis version 11. Mol. Biol. Evol. 38, 3022–3027 (2021).
|
Sources 2/ https://www.nature.com/articles/s41467-023-39416-2 The mention sources can contact us to remove/changing this article |
[ad_2]